Literature DB >> 10353493

The role of excitatory amino acid transmission within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine.

M M Heinricher1, S McGaraughty, D A Farr.   

Abstract

Two classes of neurons with distinct responses to opioids have been identified in the rostral ventromedial medulla (RVM), a region with a well-documented role in nociceptive modulation. 'Off-cells' are activated, indirectly, by opioids, and are likely to exert a net inhibitory effect on nociceptive processing. 'On-cells' are directly inhibited by opioids, and there is evidence that these neurons can, under various conditions, facilitate nociception. We showed previously that excitatory amino acid (EAA) neurotransmission is crucial to the nocifensor reflex-related on-cell burst, but plays little role in maintaining the ongoing activity of off-cells. The aim of the present study was to determine whether EAA transmission contributes to the activation of off-cells and the concomitant behavioral antinociception that follow systemic opioid administration. The non-selective EAA receptor antagonist kynurenate was infused into the RVM (1 nmol/200 nl) of lightly anesthetized rats prior to administration of morphine (1.5 mg/kg i.v). Off-cell, on-cell and neutral cell firing, as well as, tail flick response (TF) latencies were recorded. Kynurenate, significantly attenuated the characteristic opioid activation of off-cells. As a group, off-cells in kynurenate-treated animals did not become continuously active, and continued to exhibit tail-flick related pauses in firing. On-cell and neutral cell responses to opioid administration were unchanged. Opioid inhibition of the TF was also reduced, although baseline TF latency was unaffected, by RVM kynurenate. EAA-mediated activation of off-cells, thus has an important role in opioid analgesia. The present observations underscore the importance of excitatory interactions among opioid-sensitive nociceptive modulatory circuits for systemic morphine analgesia, suggesting that such interactions are a critical factor in the synergistic relationships which have been demonstrated among these sites.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353493     DOI: 10.1016/s0304-3959(98)00271-1

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  16 in total

1.  Physiological basis for inhibition of morphine and improgan antinociception by CC12, a P450 epoxygenase inhibitor.

Authors:  Mary M Heinricher; Jennifer J Maire; Delaina Lee; Julia W Nalwalk; Lindsay B Hough
Journal:  J Neurophysiol       Date:  2010-10-06       Impact factor: 2.714

2.  Chronic morphine exposure increases the proportion of on-cells in the rostral ventromedial medulla in rats.

Authors:  Ian D Meng; Ichiro Harasawa
Journal:  Life Sci       Date:  2007-02-24       Impact factor: 5.037

3.  Are opioid-sensitive neurons in the rostral ventromedial medulla inhibitory interneurons?

Authors:  D R Cleary; M J Neubert; M M Heinricher
Journal:  Neuroscience       Date:  2007-11-04       Impact factor: 3.590

4.  Neural basis for improgan antinociception.

Authors:  M M Heinricher; M E Martenson; J W Nalwalk; L B Hough
Journal:  Neuroscience       Date:  2010-05-24       Impact factor: 3.590

5.  Descending facilitatory pathways from the rostroventromedial medulla mediate naloxone-precipitated withdrawal in morphine-dependent rats.

Authors:  Louis P Vera-Portocarrero; Michael H Ossipov; Josephine Lai; Tamara King; Frank Porreca
Journal:  J Pain       Date:  2011-02-26       Impact factor: 5.820

6.  Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat.

Authors:  Michael M Morgan; Erin N Bobeck; Susan L Ingram
Journal:  Brain Res       Date:  2009-08-05       Impact factor: 3.252

7.  Lateral hypothalamic-induced antinociception may be mediated by a substance P connection with the rostral ventromedial medulla.

Authors:  Janean E Holden; Julie A Pizzi
Journal:  Brain Res       Date:  2008-04-08       Impact factor: 3.252

8.  Sustained morphine-induced sensitization and loss of diffuse noxious inhibitory controls in dura-sensitive medullary dorsal horn neurons.

Authors:  Akiko Okada-Ogawa; Frank Porreca; Ian D Meng
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

Review 9.  Descending control of nociception: Specificity, recruitment and plasticity.

Authors:  M M Heinricher; I Tavares; J L Leith; B M Lumb
Journal:  Brain Res Rev       Date:  2008-12-25

10.  NMDA receptor-mediated activation of medullary pro-nociceptive neurons is required for secondary thermal hyperalgesia.

Authors:  Mei Xu; Chang Jae Kim; Miranda J Neubert; Mary M Heinricher
Journal:  Pain       Date:  2006-09-25       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.